GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » APT Medical Inc (SHSE:688617) » Definitions » EV-to-EBITDA

APT Medical (SHSE:688617) EV-to-EBITDA : 46.76 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is APT Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, APT Medical's enterprise value is ¥29,991 Mil. APT Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥641 Mil. Therefore, APT Medical's EV-to-EBITDA for today is 46.76.

The historical rank and industry rank for APT Medical's EV-to-EBITDA or its related term are showing as below:

SHSE:688617' s EV-to-EBITDA Range Over the Past 10 Years
Min: 37.22   Med: 54.02   Max: 134.87
Current: 46.76

During the past 7 years, the highest EV-to-EBITDA of APT Medical was 134.87. The lowest was 37.22. And the median was 54.02.

SHSE:688617's EV-to-EBITDA is ranked worse than
89.17% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 15.92 vs SHSE:688617: 46.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), APT Medical's stock price is ¥453.89. APT Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥8.470. Therefore, APT Medical's PE Ratio for today is 53.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


APT Medical EV-to-EBITDA Historical Data

The historical data trend for APT Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

APT Medical EV-to-EBITDA Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 68.21 43.64 37.28

APT Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.13 46.84 43.62 37.28 42.82

Competitive Comparison of APT Medical's EV-to-EBITDA

For the Medical Devices subindustry, APT Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


APT Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where APT Medical's EV-to-EBITDA falls into.



APT Medical EV-to-EBITDA Calculation

APT Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=29990.713/641.397
=46.76

APT Medical's current Enterprise Value is ¥29,991 Mil.
APT Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥641 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


APT Medical  (SHSE:688617) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

APT Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=453.89/8.470
=53.59

APT Medical's share price for today is ¥453.89.
APT Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8.470.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


APT Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of APT Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


APT Medical (SHSE:688617) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Executives
Dai Zhen Hua Directors, senior managers
Cheng Zheng Hui Directors, senior managers
Zhang Yong Core technical personnel
Liu Fang Yuan senior management
Wang Wei senior management
Senior management, core technical personnel
Xu Yi Qing Directors, senior managers
Han Yong Gui Senior management, core technical personnel

APT Medical (SHSE:688617) Headlines

No Headlines